SamanTree Medical

Focus: SamanTree Medical is a Swiss biotechnology company focused on diagnostic imaging and margin assessment in oncology, with a specialized platform called Histolog Scanner targeting breast and prostate cancer applications.

Oncology

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About SamanTree Medical

AI assessmentNot Hiring

No open roles listed right now. Follow SamanTree Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

7 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Histolog Scanner

Margins of Excision

N/A

Clinical Trials (1)

NCT04857229Histolog Comparison to Standard Histology

N/A

Help build intelligence for SamanTree Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused technology platform with clear clinical applications in high-prevalence cancers (breast, prostate) addressing an unmet surgical need
Switzerland-based location provides access to strong biotech ecosystem and regulatory proximity to EMA
Specialized margin assessment niche offers differentiated positioning versus broader oncology players

Watch Out For

Currently zero active job openings signals minimal near-term hiring or possible early-stage/dormant status
Missing data on funding, revenue, employee count, and stage prevents assessment of financial stability and career growth trajectory

Generated by Claude from SamanTree Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Histolog Scanner

Adult Patients Undergoing a Surgery or a Medical Procedure With Use of Histolog® Scanner

N/A

Clinical Trials (1)

NCT07006090EU Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner.

N/A

Histolog® Scanner

Breast Cancer

N/A

Clinical Trials (1)

NCT07527468HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery

N/A